Patents

US 9045401 B2: Methods for treating or ameliorating a melanoma and killing melanoma cells

Granted
2015-06-02
Filed
2008-05-21 application 12600930
Type
Utility · 20 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention provides novel compositions—lipopeptides and analogs, including somocystinamide A, and somocystinamide A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and using them. In one embodiment, these lipopeptides and analogs are used to induce apoptosis in a cell, which can be a normal cell, a dysfunctional cell and/or a cancer (tumor) cell. In alternative embodiments, the compositions of the invention, including the lipopeptides and analogs of the invention, and the pharmaceutical compositions comprising them, are used to treat or ameliorate (including slowing the progression of) normal, dysfunctional (e.g., abnormally proliferating) and/or tumor associated blood vessels, including endothelial and/or capillary cell growth; including neovasculature related to (within, providing a blood supply to) a tumor.

Source: PVGPATDIS, file of 2026-04-10 (ipg150602.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 8,781 patentsUS company or organizationOakland, CAREGENTS OF THE UNIVERSITY OF CALIFORNIA State business registration FUZZY medium confidence: same name (legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
William H. GerwickVillage of La Jolla, CA6PVGPATDIS, file of 2026-04-10
Wolfgang WrasidloVillage of La Jolla, CA6PVGPATDIS, file of 2026-04-10
Dennis A. CarsonVillage of La Jolla, CA20PVGPATDIS, file of 2026-04-10
Dwayne StupackSan Diego, CA1PVGPATDIS, file of 2026-04-10
Takashi SUYAMAAlbany, OR1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07CAcyclic or carbocyclic compoundsC07C323/60PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2015-04-28Assignment
Assignment of assignor's interest
WRASIDLO, WOLFGANG signed 2015-03-06
CARSON, DENNIS signed 2015-03-06
STUPACK, DWAYNE signed 2015-03-06
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OAKLAND, CA35511/833PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.